Other studies that point to an oncogenic role of miR-223 in PC show that miR-223 mainly targets two known onco-suppressors, PDS5 cohesin-associated factor B (PDS5B/APRIN) and FBXW7 [220,221,222]. The gene discussed is PDS5B; the disease is pachyonychia congenita.